Peisheng Chen

Dr. Peisheng Chen

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
BWBo-Wei Wang
Bo-Wei Wang
YJYi Jiang
Yi Jiang
ZYZi-Long Yao
Zi-Long Yao
PCPeisheng Chen
Peisheng Chen
BYBin Yu
Bin Yu
SWSheng-Nan Wang
Sheng-Nan Wang
Objective: Chondrocyte apoptosis has also been strongly correlated with the severity of cartilage damage and matrix depletion in an osteoarthritis (OA) joint. Therefore, pharmacological inhibitors of apoptosis may provide a novel treatment option for patients with OA. Aucubin, a natural compound isolated from Eucommia ulmoides, has been proved to possess antioxidative and anti-apoptotic properties. However, anti-osteoarthritis effect of aucubin in animal model and anti-apoptotic response of aucubin in OA chondrocytes remain unclear. This study aimed to determine whether aucubin could slow progression of OA in a mouse model and inhibit the IL-1β-induced chondrocyte apoptosis. Methods: OA severity and articular cartilage degradation were evaluated by Safranin-O staining, Hematoxylin-eosin (H&E) staining, and Osteoarthritis Research Society International (OARSI) standards. Chondrocyte viability was observed by Cell Counting Kit-8 (CCK8) and live/dead cells assay; the apoptotic rate of chondrocytes was evaluated by flow cytometry (FCM) with Annexin V-FITC/PI kit. Mediators of apoptosis were tested by Western blot of Bax, caspase-3, caspase-9, and Bcl-2 expression. The intracellular levels of Reactive oxygen species (ROS) were assessed by the probe of 2,7-Dichlorofluorescin diacetate (DCFH-DA). Results: The articular cartilage in the limb with destabilization of the medial meniscus (DMM) exhibited early OA-like manifestations characterized by proteoglycan loss, cartilage fibrillation, and erosion, with lower OARSI score. Oral administration of aucubin remarkably attenuated the loss of proteoglycan and the articular cartilage erosion and decreased the OARSI scores underwent DMM surgery. Aucubin treatment significantly reverses IL-1β-induced cytotoxicity and attenuated the IL-1β-induced chondrocyte apoptosis. In addition, aucubin can significantly inhibit mediators of apoptosis in rat primary chondrocytes. Furthermore, aucubin remarkably attenuated the IL-1β-induced intracellular ROS production. Conclusion: Our findings suggest that aucubin has a protective effect on articular cartilage and slowing progression of OA in a mouse model. This protective effect may result from inhibiting chondrocyte apoptosis and excessive ROS production.

12 April 2024 in Injury
Verified
Journal Article
Closed access
SZShunze Zheng
Shunze Zheng
DLDongze Lin
Dongze Lin
PCPeisheng Chen
Peisheng Chen
CLChaohui Lin
Chaohui Lin
BCBin Chen
Bin Chen
FLFengfei Lin
Fengfei Lin

10 October 2018 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
GDGanming Deng
Ganming Deng
KLKaiqun Li
Kaiqun Li
SCSiwei Chen
Siwei Chen
PCPeisheng Chen
Peisheng Chen
HZHaonan Zheng
Haonan Zheng
KZKairui Zhang
Kairui Zhang
Tendon repair follows a slow course of early inflammatory, proliferative and remodeling phases, which commonly results in the failure and loss of normal biomechanical properties. Previous studies have demonstrated that tendon‑derived stem cells (TDSCs) are vital healing cells and that mRNA expression of anti‑inflammatory cytokine interleukin (IL)‑10 is significantly upregulated at the late inflammatory phase. To explore how IL‑10 may impact tendon healing, the present study investigated the in vitro effects of IL‑10 on TDSCs isolated from rat Achilles tendons. Cellular activities of TDSCs and the expression levels of tendon cell markers were measured treatment with IL‑10 and subsequent performance of wound healing assays, reverse transcription‑quantitative polymerase chain reaction and western blot analyses. The results demonstrated that IL‑10 treatment markedly increased the proliferative capacity of TDSCs. In addition, IL‑10 significantly enhanced cell migration when compared with the control cells. Furthermore, IL‑10 treatment significantly activated the JAK/Stat3 signaling pathway and inhibited the protein expression of tendon cell markers, including scleraxis and tenomodulin. Notably, IL‑10 treatment also reduced the gene expression levels of type 1 collagen, type 3 collagen, lumican and fibromodulin in TDSCs. These findings indicated that IL‑10 enhanced cell proliferation and migration, and inhibited tenogenic differentiation in TDSCs in vitro. Reducing the negative effects whilst enhancing the positive effects of IL‑10 may be a potential therapeutic target in tendon repair.

1 September 2020 in Journal of Orthopaedic Translation
Verified
Journal Article
Open access
YHYanjun Hu
Yanjun Hu
HWHangtian Wu
Hangtian Wu
TXTing Xu
Ting Xu
YWYutian Wang
Yutian Wang
HQHanjun Qin
Hanjun Qin
ZCZhuang Cui
Zhuang Cui
Abnormal bone formation in subchondral bone resulting from uncoupled bone remodeling is considered a central feature in osteoarthritis (OA) pathogenesis. H-type vessels can couple angiogenesis and osteogenesis. We previously revealed that elevated H-type vessels in subchondral bone were correlated with OA and focal adhesion kinase (FAK) in MSCs is critical for H-type vessel formation in osteoporosis. The aim of this study was to explore the correlation between H-type vessels and MSCs in OA pathogenesis through regulation of H-type vessel formation using defactinib (an FAK inhibitor). In vivo: 3-month-old male C57BL/6J (WT) mice were randomly divided into three groups: sham controls, vehicle-treated ACLT mice, and defactinib-treated ACLT mice (25 mg/kg, intraperitoneally weekly). In vitro: we explored the role of conditioned medium (CM) of MSCs from subchondral bone of different groups on the angiogenesis of endothelial cells (ECs). Flow cytometry, Western blotting, ELISA, real time (RT)-PCR, immunostaining, CT-based microangiography, and bone micro-CT (μCT) were used to detect changes in relative cells and tissues. This study demonstrated that inhibition of H-type vessels with defactinib alleviated OA by inhibiting H-type vessel-linked MSCs in subchondral bone. During OA pathogenesis, H-type vessels and MSCs formed a positive feedback loop contributing to abnormal bone formation in subchondral bone. Elevated H-type vessels provided indispensable MSCs for abnormal bone formation in subchondral bone. Flow cytometry and immunostaining results confirmed that the amount of MSCs in subchondral bone was obviously higher in vehicle-treated ACLT mice than that in sham controls and defactinib-treated ACLT mice. In vitro, p-FAK in MSCs from subchondral bone of vehicle-treated ALCT mice increased significantly relative to other groups. Further, the CM from MSCs of vehicle-treated ACLT mice enhanced angiogenesis of ECs through FAK-Grb2-MAPK-linked VEGF expression. Our results demonstrate that defactinib inhibits OA by suppressing the positive feedback loop between H-type vessels and MSCs in subchondral bone. Our results provide a mechanistic rationale for the use of defactinib as an effective candidate for OA treatment.

1 April 2021 in Annals of Palliative Medicine
Verified
Journal Article
Open access
PDF file
PCPeisheng Chen
Peisheng Chen
XLXiaofeng Lin
Xiaofeng Lin
BCBin Chen
Bin Chen
KZKe Zheng
Ke Zheng
CLChaohui Lin
Chaohui Lin
FLFengfei Lin
Fengfei Lin
The global state of research and trends in osteomyelitis from 2010 to 2019: a 10-year bibliometric analysis Peisheng Chen, Xiaofeng Lin, Bin Chen, Ke Zheng, Chaohui Lin, Bin Yu, Fengfei Lin

23 April 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
HWHangtian Wu
Hangtian Wu
TXTing Xu
Ting Xu
ZCZhigang Chen
Zhigang Chen
YWYutian Wang
Yutian Wang
KLKaiqun Li
Kaiqun Li
ZCZhuang Cui
Zhuang Cui